Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in COVID-19 (SC vs IV)
NCT04462757Phase 2Terminated
- Sponsor
- The University of Manchester
- Start
- May 2020
- Primary completion
- Aug 2020
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of anakinra in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by The University of Manchester. Primary endpoints: Plasma IL-1Ra at 1 week and Plasma IL-6 at 1 week. Started May 2020; status: terminated.
02
Drugs
anakinra
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04462757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04462757.